638 related articles for article (PubMed ID: 30262739)
21. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
[TBL] [Abstract][Full Text] [Related]
22. Biosensors and bioassays for determination of matrix metalloproteinases: state of the art and recent advances.
Lei Z; Jian M; Li X; Wei J; Meng X; Wang Z
J Mater Chem B; 2020 Apr; 8(16):3261-3291. PubMed ID: 31750853
[TBL] [Abstract][Full Text] [Related]
23. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.
Thrailkill KM; Moreau CS; Cockrell G; Simpson P; Goel R; North P; Fowlkes JL; Bunn RC
Clin Chem Lab Med; 2005; 43(12):1392-9. PubMed ID: 16309379
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes.
Cheng N; Du D; Wang X; Liu D; Xu W; Luo Y; Lin Y
Trends Biotechnol; 2019 Nov; 37(11):1236-1254. PubMed ID: 31104858
[TBL] [Abstract][Full Text] [Related]
25. Effective voltammetric tool for simultaneous detection of MMP-1, MMP-2, and MMP-9; important non-small cell lung cancer biomarkers.
Kowalczyk A; Nisiewicz MK; Bamburowicz-Klimkowska M; Kasprzak A; Ruzycka-Ayoush M; Koszytkowska-Stawińska M; Nowicka AM
Biosens Bioelectron; 2023 Jun; 229():115212. PubMed ID: 36958204
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
[TBL] [Abstract][Full Text] [Related]
27. Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.
Jonsson A; Hjalmarsson C; Falk P; Ivarsson ML
Med Oncol; 2018 Mar; 35(4):50. PubMed ID: 29520667
[TBL] [Abstract][Full Text] [Related]
28. Fluorescent polymer dots and graphene oxide based nanocomplexes for "off-on" detection of metalloproteinase-9.
Li Q; Wang Y; Yu G; Liu Y; Tang K; Ding C; Chen H; Yu S
Nanoscale; 2019 Nov; 11(43):20903-20909. PubMed ID: 31660560
[TBL] [Abstract][Full Text] [Related]
29. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
30. Enzymatic cleavage of specific dipeptide conjugated with ferrocene as a flexible ultra-sensitive and fast voltammetric assay of matrix metalloproteinase-9 considered a prognostic cancer biomarker in plasma samples.
Nisiewicz MK; Kowalczyk A; Gajda A; Kasprzak A; Bamburowicz-Klimkowska M; Grudzinski IP; Nowicka AM
Biosens Bioelectron; 2022 Jan; 195():113653. PubMed ID: 34563889
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2001; 15(1):71-6. PubMed ID: 11286133
[TBL] [Abstract][Full Text] [Related]
32. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
In Vivo; 2001; 15(2):175-80. PubMed ID: 11317524
[TBL] [Abstract][Full Text] [Related]
33. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.
Masson V; de la Ballina LR; Munaut C; Wielockx B; Jost M; Maillard C; Blacher S; Bajou K; Itoh T; Itohara S; Werb Z; Libert C; Foidart JM; Noël A
FASEB J; 2005 Feb; 19(2):234-6. PubMed ID: 15550552
[TBL] [Abstract][Full Text] [Related]
34. Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression.
Reddy RA; Sai Varshini M; Kumar RS
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37861020
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
36. Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.
Li S; Pritchard DM; Yu LG
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805035
[TBL] [Abstract][Full Text] [Related]
37. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
38. Novel electrogravimetric biosensors for the ultrasensitive detection of plasma matrix metalloproteinase-2 considered a potential tumor biomarker.
Nisiewicz MK; Gajda A; Kowalczyk A; Cupriak A; Kasprzak A; Bamburowicz-Klimkowska M; Grudzinski IP; Nowicka AM
Anal Chim Acta; 2022 Jan; 1191():339290. PubMed ID: 35033237
[TBL] [Abstract][Full Text] [Related]
39. Quantum dots based molecular beacons for in vitro and in vivo detection of MMP-2 on tumor.
Li X; Deng D; Xue J; Qu L; Achilefu S; Gu Y
Biosens Bioelectron; 2014 Nov; 61():512-8. PubMed ID: 24951921
[TBL] [Abstract][Full Text] [Related]
40. Genetically encoded FRET-based biosensor for imaging MMP-9 activity.
Stawarski M; Rutkowska-Wlodarczyk I; Zeug A; Bijata M; Madej H; Kaczmarek L; Wlodarczyk J
Biomaterials; 2014 Feb; 35(5):1402-10. PubMed ID: 24290700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
